Skip to main content

Table 2 Short- and long-term survival for resected pancreatic cancer patients receiving chemotherapy estimated by the Kaplan-Meier method

From: Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study

Survival

The US

Belgium

The Netherlands

Slovenia

Norway

OS (95% CI)1

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

Short-term survival

 6-month

94 (94–95)

95 (94–96)

97 (96–98)

95 (89–98)

96 (91–99)

 9-month

87 (86–87)

86 (84–88)

89 (87–91)

79 (70–85)

90 (83–94)

Long-term survival

 1-year

77 (76–78)

77 (74–79)

79 (77–82)

69 (60–77)

77 (67–83)

 2-year

47 (46–48)

46 (43–49)

44 (40–47)

39 (30–47)

46 (36–55)

 3-year

31 (30–32)

29 (26–32)

29 (25–32)

21 (14–29)

27 (18–36)

 5-year

19 (18–20)

17 (14–20)

20 (16–23)

10 (5–17)

21 (12–31)

  1. 1Results were calculated using the Kaplan-Meier method and are shown as survival proportions (95% confidence intervals) [%]
  2. OS overall survival, CI confidence interval